Michael Rosenblatt
Direttore/Membro del Consiglio presso PYC THERAPEUTICS LIMITED
Patrimonio netto: 704 920 $ in data 31/01/2025
Profilo
Michael A.
Rosenblatt was the founder of Theracrine, Inc. (2006) and Radius Health, Inc. (2003) with the title of Director.
Current jobs include Non-Executive Director at PYC Therapeutics Ltd.
(2021), Director at Ferring Pharmaceuticals, Inc. (2016), Non-Executive Director at Perspectum Ltd., Director at Ohana Biosciences, Inc. (2016), Director at Cygnal Therapeutics, Inc. (2016), Director at Perspectum Group Ltd.
(2022), Senior Advisor at Flagship Pioneering, Inc. (2022), and Advisor at PureTech Health LLC.
Former jobs include Non-Executive Director at Shire Plc (2008), Non-Executive Director at Shire Plc (2008-2009), Director at ProScript, Inc., Director at Project HOPE-The-People-To-People Health Foundation, Inc., Director at Harvard Mit Health Sciences & Technology (1998), Independent Director at Axcella Health, Inc. (2022-2023), Independent Director at Rubius Therapeutics, Inc. (2014-2023), Director at Cobalt Biomedicine, Inc., Independent Director at Azenta, Inc. (2018-2025), Chief Medical Officer & Executive Vice President at Merck & Co., Inc. (1984-2016), Chief Medical Officer at Schering-Plough Corp., Principal at The General Hospital Corp.
(1981-1984), Senior Vice President-Academic Programs at CareGroup, Inc. (2000), President at Beth Israel Deaconess Medical Center, Inc. (1996-2003), Member-Scientific Counselors Board at National Institute of Diabetes & Digestive & Kidney Diseases, Senior Vice President-Research at Merck Research Laboratories Massachusetts LLC, Professor at Harvard Medical School, Senior Vice President-Research at Merck Sharp & Dohme Corp.
(1992), Professor at Molecular Medicine LLC, and Dean at Tufts University School of Medicine.
Education includes undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate from Harvard Medical School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
AZENTA, INC.
0,03% | 09/12/2024 | 13 042 ( 0,03% ) | 704 920 $ | 31/01/2025 |
PYC THERAPEUTICS LIMITED
-.--% | 30/06/2024 | 0 ( -.--% ) | - $ | 31/01/2025 |
Ultime notizie su Michael Rosenblatt
Posizioni attive di Michael Rosenblatt
Società | Posizione | Inizio |
---|---|---|
PYC THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 17/03/2021 |
Perspectum Group Ltd.
![]() Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | 25/02/2022 |
Perspectum Ltd.
![]() Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | Direttore/Membro del Consiglio | - |
Flagship Pioneering, Inc.
![]() Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering, Inc. (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Consulente / Consigliere | 01/01/2022 |
Ohana Biosciences, Inc.
![]() Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/01/2016 |
Cygnal Therapeutics, Inc.
![]() Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/01/2016 |
Puretech Health LLC
![]() Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | 29/12/2010 |
Ferring Pharmaceuticals, Inc.
![]() Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Direttore/Membro del Consiglio | 01/01/2016 |
Precedenti posizioni note di Michael Rosenblatt
Società | Posizione | Fine |
---|---|---|
AZENTA, INC. | Direttore/Membro del Consiglio | 30/01/2025 |
░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Michael Rosenblatt
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
AZENTA, INC. | Health Services |
PYC THERAPEUTICS LIMITED | Health Technology |
Aziende private | 24 |
---|---|
Radius Health, Inc.
![]() Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
ProScript, Inc.
![]() ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Millennium Pharmaceuticals, Inc., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Millennium Pharmaceuticals, Inc. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
Puretech Health LLC
![]() Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Shire Plc
![]() Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
![]() Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
CareGroup, Inc.
![]() CareGroup, Inc. Miscellaneous Commercial ServicesCommercial Services CareGroup, Inc. provides medical and surgical services. Its health care services include orthopedics, obstetrics, diabetes, and cardiovascular disease. The company was founded on June 22, 1984 and is headquartered in Boston, MA. | Commercial Services |
Merck Sharp & Dohme Corp.
![]() Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Health Technology |
The General Hospital Corp.
![]() The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Project HOPE-The-People-To-People HealthFoundation, Inc.
![]() Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Health Services |
Rubius Therapeutics, Inc.
![]() Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Theracrine, Inc.
![]() Theracrine, Inc. BiotechnologyHealth Technology Theracrine, Inc. develops anti-metastatic drugs for cancer therapeutics. It provides scientific and technological services as well as research and design relating thereto. The company was founded by David A. Berry, Noubar B. Afeyan, Robert A. Weinberg, Joan Massagué and Douglas Hanahan in 2006 and is headquartered in Cambridge, MA. | Health Technology |
Cygnal Therapeutics, Inc.
![]() Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Ohana Biosciences, Inc.
![]() Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Commercial Services |
Flagship Pioneering, Inc.
![]() Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering, Inc. (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Molecular Medicine LLC | |
Cobalt Biomedicine, Inc.
![]() Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Perspectum Ltd.
![]() Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | Health Services |
Axcella Health, Inc.
![]() Axcella Health, Inc. BiotechnologyHealth Technology Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non-alcoholic steatohepatitis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
National Institute of Diabetes & Digestive & Kidney Diseases | Government |
Merck Research Laboratories Massachusetts LLC
![]() Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Perspectum Group Ltd.
![]() Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
Ferring Pharmaceuticals, Inc.
![]() Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
- Borsa valori
- Insiders
- Michael Rosenblatt